质子抑制剂 (PPI) 使用对偏头痛的影响 - - 批判性审查
Viktoria Tischler-Strasser1,2, Irma Burdiladze3, Goncalo Cabral4
1Department of Neurology, Koventhospital Barmherzige Brüder, Linz, Austria.
The journal of headache and pain
|January 30, 2025
概括
质子抑制剂 (PPI) 可能与头痛和偏头痛有关. 虽然PPI对与酸有关的疾病是有效的,但在患有头痛的患者中,它们的使用需要谨慎.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 胃肠病学 胃肠病学
背景情况:
- 质子抑制剂 (PPI) 广泛用于胃酸相关疾病.
- 偏头痛和PPI使用都很普遍,影响了许多人.
- 人们越来越关注PPI摄入量与头痛 (尤其是偏头痛) 的发展之间的潜在关联.
研究的目的:
- 批判性地检查PPI使用和头痛/偏头痛的同时发生的科学数据.
- 评估有关PPI和偏头痛之间潜在联系的现有证据.
- 探索潜在的病理生理学联系和相互作用.
主要方法:
- 科学文献的叙述性审查.
- 对PPI和头痛的现有数据进行批判性评估.
- 分析潜在的促成因素,如遗传学和肠道微生物群.
主要成果:
- 在PPI使用和头痛发生之间存在可能的联系,特别是偏头痛.
- 个人防护剂可能会产生副作用,即使不立即明显.
- 这种关系的性质 (因果关系与共存关系) 仍然不清楚,受多种因素的影响.
结论:
- 偏头痛患病率和PPI使用之间的关系似乎是可能的.
- 在患有头痛和偏头痛的患者中,应谨慎处方PPI.
- 需要进一步的研究来了解PPI和偏头痛之间的相互作用.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
350
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
350
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
329
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
329
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
204
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
204
Cholinergic Antagonists: Therapeutic Uses
704
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
704
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
398
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
398


